UNLIMITED FREE
ACCESS
TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

HHS - 21 CFR PART 1107

EXEMPTION REQUESTS AND SUBSTANTIAL EQUIVALENCE REPORTS

active, Most Current
Organization: HHS
Publication Date: 1 April 2023
Status: active
Page Count: 39
scope:

(a) Subparts B through E of this part apply to a substantial equivalence report (or an SE Report) for a new tobacco product, other than ''premium'' cigars as defined in § 1107.12, that has:

(1) Characteristics different from a predicate tobacco product and for which information is submitted to demonstrate it is not appropriate to regulate the product under section 910(b) and (c) of the Federal Food, Drug, and Cosmetic Act because the new tobacco product does not raise different questions of public health or

(2) The same characteristics as a predicate tobacco product.

(b) These subparts set forth procedures and requirements for the submission to FDA of an SE Report under sections 905 and 910 of the Federal, Food, Drug, and Cosmetic Act; the basic criteria for establishing substantial equivalence; and the general procedures FDA will follow when evaluating submissions.

Document History

21 CFR PART 1107
April 1, 2023
EXEMPTION REQUESTS AND SUBSTANTIAL EQUIVALENCE REPORTS
(a) Subparts B through E of this part apply to a substantial equivalence report (or an SE Report) for a new tobacco product, other than ‘‘premium’’ cigars as defined in § 1107.12, that has: (1)...
April 1, 2022
EXEMPTION REQUESTS AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2021
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2020
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2019
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2018
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2017
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2016
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
General requirements. Under section 905(j)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 387e(j)(3)), FDA may exempt from the requirements relating to the demonstration that a tobacco...
April 1, 2015
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
April 1, 2014
ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
A description is not available for this item.
Advertisement